verified SJR 28,675 · Q1 • database Scopus / SJR & Web of Science indexed

United Kingdom · Nature Publishing Group

workspace_premium Q1 — Oncology lock Subscription

Nature Reviews Clinical Oncology

Nature Reviews Clinical Oncology is a journal indexed in SJR in Oncology with an H index of 238. It has an SJR impact factor of 28,675 and it has a best quartile of Q1. It has an SJR impact factor of 28,675.

Nature Reviews Clinical Oncology focuses its scope in these topics and keywords: biomarkerdriven, trials, cancer, biopsy, discovery, clinical, standard, drug, irradiation, matchmet, ...

ISSN: 1759-4774

Publisher: Nature Publishing Group

Category: Oncology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD Subscribe

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

28,675 Q1

H-index 238

Acceptance rate pie_chart

20% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

28,675

H-index

238

Docs (year)

130

Docs 3y

382

Total refs

9101

Cites 3y

13125

Citable 3y

180

Cites/Doc 2y

33.23

Ref/Doc

70.01

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Cetuximab's tip to become irresistible

Will an aspirin a day keep the colorectal cancer away?

Erratum: Managing bone metastases and reducing skeletal related events in prostate cancer

Erratum: Clinical trials of human papillomavirus vaccines and beyond

Driver genes are mutated early in the course of oesophageal adenocarcinoma

Does nodal micrometastasis impact outcome in biliary cancer?

Dacomitinib: getting on target after negative ARCHER trial

CTCs - a predictive approach for targeted cancer therapy

CSF DNA provides a snapshot of the glioma genome

CRISPR-Cas: a tool for cancer research and therapeutics

Conscripts of the infinite armada: systemic cancer therapy using nanomaterials

CONKO conquers

SHOW MORE ARTICLES

Cisplatin more effective when given less often

A case of variant angina in a patient under chronic treatment with sorafenib

Celebrating 10 years since launch

Can less really be more in melanoma?

BRAF and MEK inhibitors - good news comes in twos!

Bortezomib and dexamethasone induction for multiple myeloma

Biomarker potential of CA-125 enhanced

ARAMIS - is darolutamide set to become the 'third musketeer' of nmCRPC?

ALL: reducing cardiomyopathy

Advanced Hodgkin lymphoma - balancing toxicity and cure

ADAM8 provides new hope in pancreatic cancer

Abiraterone treatment improves overall survival in patients with mCRPC

FAQs

Nature Reviews Clinical Oncology has an SJR of 28,675 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Nature Reviews Clinical Oncology is 20%.

Nature Reviews Clinical Oncology

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Nature Reviews Clinical Oncology?

What is the APC / publication cost?

What is the acceptance rate?